Treatment of psychiatric comorbidities in a patient with becker muscular dystrophy.
Chaichana
Kaisorn L
KL
Department of Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Buffington
Angela L H
AL
Brandes
Mina
M
Edwin
David
D
Lee
Hochang B
HB
D000328:Adult; D001521:Behavior Therapy / Q000379:methods; D015897:Comorbidity; D000068736:Duloxetine Hydrochloride; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000453:epidemiology*; D020388:Muscular Dystrophy, Duchenne / Q000453:epidemiology* / Q000628:therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use
D000068736:Duloxetine Hydrochloride; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes